Neoadjuvant chemotherapy using taxanes in the combination treatment of non-small cell lung cancer

The results of combination treatment with neoadjuvant chemotherapy using paclitaxel/carboplatin and docetaxel/cisplatin regimens, radical surgery, and 15-Gy intraoperative radiotherapy (IORT) were studied in 105 patients with stage III non-small cell lung cancer. Neoadjuvant chemotherapy resulted in a high immediate response rate (40.2 ± 5.7%). Chemotherapy response is directly correlated with tumor tissue involvement confirmed by histological examination. Preoperative systemic anti-tumor therapy showed a statistically significant increase in relapse-free and overall survivals in patients with locally advanced non-small cell lung cancer.

non-small cell lung cancer, surgical treatment, chemotherapy, intraoperative radiation